ScienceDex / Researcher record
Cesar M Castro
- Massachusetts General Hospital · Internal Medicine (investigator's affiliation)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
Start from a Word CV, PubMed IDs or ORCID.
- Program Leader
- R01 Holder
- Early Career
NIH Funding · FY2026
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $2,131,460 | 4 | #4,791 |
| 2025 | $4,317,450 | 5 | #1,811 |
| 2026 | $2,110,174 | 5 | #9,897 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20244 records
- FY20255 records
- FY2026 · selected5 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Citation measures
From OpenAlex data as of September 23, 2026. Google Scholar and Scopus count other sources, so their numbers differ.
Each number opens a page that explains the measure and compares researchers on it.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 1949625Search this ID in NIH RePORTER
- ORCID iD
- https://orcid.org/0000-0002-1159-5658Verified identifier for this researcher
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award records by amount
NIH award records listing Cesar M Castro as a PI. Multi-PI records show the full award amount for context.
- 5U01CA284982-04U01Co-investigatorExpanding early cancer detection with high throughput OCEANA - Ovarian Cancer Exosome Analysis with Nanoplasmonic ArrayMassachusetts General Hospital · Radiology (investigator's affiliation)$941.2Kaward amount
- 1R01CA310785-01R01Contact PIA CRISPR-based sensitive liquid biopsy for endometrial cancer using tumor-derived hallmarks (CRISPR SLEUTH)Massachusetts General Hospital · Internal Medicine (investigator's affiliation)$650.5Kaward amount
- 5U01CA279858-04U01Contact PIComposing CODAs to cervical cancer screening through an integrated CRISPR and fluorescent nucleic acid approachMassachusetts General Hospital · Internal Medicine (investigator's affiliation)$267.4Kaward amount
- 3U01CA279858-04S2U01Contact PIComposing CODAs to cervical cancer screening through an integrated CRISPR and fluorescent nucleic acid approachMassachusetts General Hospital · Internal Medicine (investigator's affiliation)$126.6Kaward amount
- 3U01CA279858-04S1U01Contact PIComposing CODAs to cervical cancer screening through an integrated CRISPR and fluorescent nucleic acid approachMassachusetts General Hospital · Internal Medicine (investigator's affiliation)$124.5Kaward amount
Award organization
Organizations that administered FY2026 awards listing Cesar M Castro as a PI.
FY2026 award administered by Massachusetts General Hospital (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardMassachusetts General Hospital
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #4791
- 2024Entered Top 25% NationallyRanked #4791
- 2025$5M Cumulative Funding
- 2025Entered Top 10% NationallyRanked #1811
- 2025R01 Grant Holder
- 2025Program/Center Grant Leader
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Cesar M Castro.